The role of autophagy induced by pemetrexed in lung adenocarcinoma cells

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2365-2370

  Park, Ji Hye ^a   Lee, Young Rae ^a,b   So, Hong Seob ^a   Lee, Kang Kyoo ^a   Lee, Sam Youn ^a   Moon, Sun Rock ^a   Jo, Hyang Jeong ^a   Lee, Seoul ^a   Jeong, Kyuyong ^a   Kwon, Kang Beom ^a   Yang, Sei Hoon ^a  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

Author keywords

3 MA; Autophagy; Lung cancer; Pemetrexed

Indexed keywords

ACRIDINE ORANGE; CELL PROTEIN; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEMETREXED; PROPIDIUM IODIDE; PROTEIN LC3 II; UNCLASSIFIED DRUG; 3-METHYLADENINE; ADENINE; ANTINEOPLASTIC ANTIMETABOLITE; GLUTAMIC ACID DERIVATIVE; GUANINE; THYMIDYLATE SYNTHASE;

ACIDIC VESICULAR ORGANELLE; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL DEATH; CELL ORGANELLE; CELL STRAIN A549; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME DEGRADATION; HUMAN; HUMAN CELL; INCUBATION TIME; LUNG ADENOCARCINOMA; MTT ASSAY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; WESTERN BLOTTING; ADENOCARCINOMA; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECTS; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADENINE; ADENOCARCINOMA; ANNEXIN A5; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL SURVIVAL; GLUTAMATES; GUANINE; HUMANS; LUNG NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; THYMIDYLATE SYNTHASE;

EID: 84898605705     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3071     Document Type: Article

References (28)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012
2. D'Addario G, Felip E; ESMO Guidelines Working Group: Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20 (Suppl 4): 68-70, 2009
3. Gkiozos I, Charpidou A and Syrigos K: Developments in the treatment of non-small cell lung cancer. Anticancer Res 27: 2823-2827, 2007
4. Scagliotti GV, Parikh P, von Pawel J, et al: Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26: 3543-3551, 2008
5. Katayama M, Kawaguchi T, Berger MS and Pieper RO: DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ 14: 548-558, 2007
6. Levine B and Yuan J: Autophagy in cell death: An innocent convict? J Clin Invest 115: 2679-2688, 2005
7. Ravikumar B, Sarkar S, Davies JE, et al: Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90: 1383-1435, 2010
8. Gozuacik D and Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906, 2004
9. Rollins KD and Lindley C: Pemetrexed: A multitargeted antifolate. Clin Ther 27: 1343-1382, 2005
10. Ramirez JM, Ocio EM, San Miguel JF and Pandiella A: Pemetrexed acts as an antimyeloma agent by provoking cell cycle blockade and apoptosis. Leukemia 21: 797-804, 2007
11. Yang TY, Chang GC, Chen KC, et al: Pemetrexed induces both intrinsic and extrinsic apoptosis through ataxia telangiectasia mutated/p53-dependent and -independent signaling pathways. Mol Carcinog 52: 183-194, 2013
12. Tonkinson JL, Worzalla JF, Teng CH and Mendelsohn LG: Cell cycle modulation by a multitargeted antifolate, LY231514, increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma. Cancer Res 59: 3671-3676, 1999
13. McLeod HL, Cassidy J, Powrie RH, et al: Pharmacokinetic and pharmacodynamic evaluation of the glycinamide ribonucleotide formyltransferase inhibitor AG2034. Clin Cancer Res 6: 2677-2684, 2000
14. Shih C, Chen VJ, Gossett LS, et al: LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes. Cancer Res 57: 1116-1123, 1997
15. D'Angelo SP, Kris MG, Pietanza MC, Rizvi NA and Azzoli CG: A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed. J Thorac Oncol 6: 624-626, 2011
16. Mujumdar N, Mackenzie TN, Dudeja V, et al: Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways. Gastroenterology 139: 598-608, 2010
17. Hanna N, Shepherd FA, Fossella FV, et al: Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 22: 1589-1597, 2004
18. Ciuleanu T, Brodowicz T, Zielinski C, et al: Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase 3 study. Lancet 374: 1432-1440, 2009
19. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al: Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21: 2636-2644, 2003
20. Bareford MD, Hamed HA, Tang Y, et al: Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Autophagy 7: 1261-1262, 2011
21. Nakai A, Yamaguchi O, Takeda T, et al: The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13: 619-624, 2007
22. Kondo Y, Kanzawa T, Sawaya R and Kondo S: The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5: 726-734, 2005
23. Baehrecke EH: Autophagy: Dual roles in life and death? Nat Rev Mol Cell Biol 6: 505-510, 2005
24. Debnath J, Baehrecke EH and Kroemer G: Does autophagy contribute to cell death? Autophagy 1: 66-74, 2005
25. Zeng X, Overmeyer JH and Maltese WA: Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci 119: 259-270, 2006
26. Pattingre S, Espert L, Biard-Piechaczyk M and Codogno P: Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90: 313-323, 2008
27. Kanematsu S, Uehara N, Miki H, et al: Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. Anticancer Res 30: 3381-3390, 2010
28. Liu D, Yang Y, Liu Q and Wang J: Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells. Med Oncol 28: 105-111, 2011